Martha E. Linsenmeyer
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 3
- CRISPR and Genetic Engineering 2
- Cancer-related gene regulation 2
- Cancer therapeutics and mechanisms 2
- Advanced biosensing and bioanalysis techniques 2
- Oncology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- David M. Woodcock (12 shared papers)Judith P. Doherty (5 shared papers)William Warren (3 shared papers)Penelope J. Crowther (4 shared papers)Michael Millward (4 shared papers)Lorraine K. Webster (3 shared papers)James F. Bishop (3 shared papers)Ivan Bertoncello (1 shared paper)
In The Last Decade
Martha E. Linsenmeyer
13 papers receiving 560 citations
Peers
Comparison fields: 5 of 74
- Oncology 257
- Pharmaceutical Science 28
- Biomaterials 57
- Pharmacology 34
- Molecular Biology 269
Countries citing papers authored by Martha E. Linsenmeyer
This map shows the geographic impact of Martha E. Linsenmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Linsenmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Linsenmeyer more than expected).
Fields of papers citing papers by Martha E. Linsenmeyer
This network shows the impact of papers produced by Martha E. Linsenmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Linsenmeyer. The network helps show where Martha E. Linsenmeyer may publish in the future.
Co-authors
The 24 scholars most cited alongside Martha E. Linsenmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. | 1990 | 158 |
| 2 | 1997 | 127 | |
| 3 | 1993 | 124 | |
| 4 | 1991 | 37 | |
| 5 | 1998 | 34 | |
| 6 | 1997 | 32 | |
| 7 | Phase I trial of cremophor EL with bolus doxorubicin. | 1998 | 30 |
| 8 | 2002 | 13 | |
| 9 | 1998 | 11 | |
| 10 | 1991 | 9 | |
| 11 | 1994 | 6 | |
| 12 | 1991 | 2 | |
| 13 | 1994 | 2 |
About Martha E. Linsenmeyer
Martha E. Linsenmeyer is a scholar working on Molecular Biology, Oncology, Genetics, Biophysics and Ecology, having authored 13 papers that have together received 585 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers), CRISPR and Genetic Engineering (2 papers), Bacteriophages and microbial interactions (2 papers), Chromosomal and Genetic Variations (2 papers), Cancer-related gene regulation (2 papers), Cancer therapeutics and mechanisms (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Oncology (257 citations), Pharmaceutical Science (28 citations), Biomaterials (57 citations), Pharmacology (34 citations) and Molecular Biology (269 citations). Martha E. Linsenmeyer has collaborated with scholars based in Australia and Germany. Frequent co-authors include David M. Woodcock, Judith P. Doherty, William Warren, Penelope J. Crowther, Michael Millward, Lorraine K. Webster, James F. Bishop, Ivan Bertoncello, Grace M. Chojnowski and B T Williams. Their work appears in journals such as Gene, Journal of Biological Chemistry, Biochemical Journal, British Journal of Cancer and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.